Wegovy long-term side effects: what to watch
Wegovy long-term side effects can include gallbladder disease, pancreatitis, kidney injury, and possible thyroid tumor risk. Know what to watch for.
Key facts
- Semaglutide + B12 is $157/month (billed $157 every 4 weeks), charged only after a clinician approves it.
- Answer a few health questions online. A licensed clinician reviews them. If approved, it ships to your door.
- Adults 18 or older. A licensed clinician reviews your health history and decides whether treatment is appropriate for you. Availability depends on the state you live in.
If you are searching for wegovy long-term side effects, you are usually trying to separate expected stomach symptoms from risks that need medical attention. Wegovy (semaglutide) can cause ongoing gastrointestinal side effects for some people, and it also has less common but more serious risks that can show up after you have been on it for a while. A qualified clinician can explain the evidence, possible risks, and alternatives for your individual situation.
- Wegovy long-term side effects can include gallbladder disease, pancreatitis, kidney injury, and a thyroid tumor warning.
- Most nausea, vomiting, diarrhea, constipation, and reflux are most common early and during dose increases.
- Persistent severe belly pain, dehydration, or yellowing skin are reasons to seek urgent evaluation.
- If you have a personal or family history of medullary thyroid carcinoma, semaglutide is not recommended.
What are Wegovy long-term side effects?
Ongoing GI symptoms
Nausea, vomiting, diarrhea, constipation, belly pain, and reflux can persist in some people, especially with dose escalation. These are common side effects in the FDA label and are often manageable with clinician-guided adjustments and hydration strategies. If symptoms are severe or do not improve, you should contact your prescriber.
Gallbladder disease
Semaglutide can be associated with gallbladder problems, including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis). These may present as right upper belly pain, nausea or vomiting, fever, or yellowing of the skin or eyes. The Wegovy label advises evaluation if gallbladder disease is suspected.
Pancreatitis
Acute pancreatitis has been reported with GLP-1 receptor agonists, including semaglutide. A classic warning sign is persistent severe abdominal pain that may radiate to the back, sometimes with vomiting. The Wegovy label advises stopping the medication and seeking medical evaluation if pancreatitis is suspected.
Kidney injury from dehydration
Severe vomiting or diarrhea can lead to dehydration, which can worsen kidney function or trigger acute kidney injury, especially in people with existing kidney disease. Signs can include very low urine output, dizziness, fainting, or inability to keep fluids down. The Wegovy label recommends monitoring kidney function when severe GI reactions occur.
Thyroid C-cell tumor warning
Wegovy carries a boxed warning about the risk of thyroid C-cell tumors seen in rodents; it is unknown whether this risk applies to humans. Because of this, Wegovy is contraindicated if you or a family member has medullary thyroid carcinoma (MTC) or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). Report a neck lump, hoarseness, trouble swallowing, or shortness of breath to a clinician.
Long-term risks and what they can feel like
Nausea and vomiting
These are among the most common Wegovy side effects and may recur with dose increases. Over the long term, the main concern is dehydration and electrolyte imbalance if you cannot keep fluids down. Contact your clinician if vomiting is persistent, you feel faint, or you are not urinating normally.
Diarrhea or constipation
Changes in bowel habits are common with semaglutide and can persist for some people. Long-lasting diarrhea can cause dehydration, while severe constipation can cause significant belly pain and reduced appetite. Seek care if you have severe pain, blood in stool, or signs of dehydration.
GERD and stomach discomfort
Reflux, burping, and upper abdominal discomfort can continue because semaglutide slows stomach emptying. If you develop severe or worsening symptoms, trouble swallowing, or vomiting that does not improve, you should be evaluated. The label also warns about severe GI reactions in some patients.
Gallstones and cholecystitis
Gallbladder events are listed in Wegovy labeling and may occur during longer-term use. Typical symptoms include right upper abdominal pain (sometimes after meals), nausea or vomiting, fever, or jaundice. Your clinician may order imaging and labs if gallbladder disease is suspected.
Pancreatitis warning signs
Pancreatitis is uncommon but serious. Persistent severe abdominal pain, especially if it radiates to the back and is associated with vomiting, should be treated as urgent. The Wegovy label advises discontinuation if pancreatitis is suspected and not restarting if confirmed.
Kidney problems from fluid loss
Acute kidney injury has been reported, sometimes in people without known kidney disease, often in the setting of nausea, vomiting, or diarrhea. If you cannot maintain hydration, feel lightheaded, or notice decreased urination, you should seek prompt medical advice. The label recommends monitoring kidney function when severe GI symptoms occur.
When to call a clinician or seek urgent care
Seek urgent evaluation for pancreatitis symptoms
Get urgent care for persistent severe abdominal pain that may radiate to your back, especially with vomiting. This is a key warning sign described in the Wegovy labeling. Do not try to manage severe pain at home.
Call promptly for gallbladder symptoms
Right upper abdominal pain, fever, or yellowing skin or eyes can suggest gallbladder disease. Wegovy labeling advises evaluation when gallbladder disease is suspected. Early assessment helps prevent complications.
Get help if you cannot stay hydrated
Repeated vomiting or diarrhea can lead to dehydration and kidney injury. If you feel faint, have very low urine output, or cannot keep fluids down, contact a clinician urgently. The label recommends monitoring kidney function when severe GI reactions occur.
Report possible thyroid warning signs
Tell a clinician if you notice a neck lump, hoarseness, trouble swallowing, or shortness of breath. Wegovy has a boxed warning for thyroid C-cell tumors based on animal data, and it is contraindicated with MTC or MEN 2. Your clinician can decide what evaluation is appropriate.
Practical tips for monitoring long-term safety
Track symptom patterns
Note when symptoms happen, how long they last, and what makes them worse or better.
Prioritize hydration
If GI symptoms flare, focus on fluids and contact a clinician early if you cannot keep liquids down.
Know the red flags
Severe belly pain, jaundice, fainting, or very low urine output should not be ignored.
Review your medication list
Ask about interactions and low blood sugar risk if you also take insulin or sulfonylureas.
Use labs when symptoms suggest it
If your clinician suspects pancreatitis or dehydration, labs can help guide next steps.
Frequently Asked Questions
What are the most important wegovy long-term side effects to watch for?
The Wegovy label highlights serious risks such as pancreatitis, gallbladder disease, and acute kidney injury (often related to dehydration from severe GI symptoms). It also carries a boxed warning about thyroid C-cell tumors and is contraindicated with MTC or MEN 2. Seek urgent care for severe persistent abdominal pain.
Do Wegovy side effects go away over time?
Many common side effects like nausea, diarrhea, constipation, and reflux are most noticeable when starting or increasing the dose, and they may improve as your body adjusts. Some people have persistent symptoms, especially if they cannot tolerate dose escalation. If symptoms are severe or ongoing, contact your prescriber.
Can Wegovy cause pancreatitis months later?
Pancreatitis has been reported with semaglutide and other GLP-1 receptor agonists and can occur during treatment, not only at the beginning. The Wegovy label advises stopping the medication and getting medical evaluation if pancreatitis is suspected. Persistent severe abdominal pain, with or without vomiting, is a key warning sign.
What symptoms could mean gallbladder problems on Wegovy?
Gallbladder disease can present as right upper abdominal pain, nausea or vomiting, fever, or yellowing of the skin or eyes. Wegovy labeling notes gallbladder events and recommends evaluation if gallbladder disease is suspected. A clinician may use imaging and labs to assess the cause.
Is compounded semaglutide the same as Wegovy?
No. Wegovy is a brand product, while compounded semaglutide is prepared by a licensed pharmacy for an individual prescription and is not FDA-approved. If you are considering a compounded option, discuss safety monitoring, side effects, and follow-up with a licensed clinician.